Ganga Pharmaceuticals Ltd. - Research Center
539680 GANGAPHARM Group (M) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
1.32 |
1.35 |
1.24 |
1.25 |
1.14 |
Operating profit |
0.05 |
0.07 |
0.01 |
0.03 |
0.08 |
Interest |
0.09 |
0.12 |
0.09 |
0.10 |
0.09 |
Gross profit |
0.05 |
0.07 |
0.07 |
0.03 |
0.05 |
EPS (Rs) |
0.04 |
0.08 |
0.08 |
0.01 |
0.04 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.09 |
0.12 |
0.15 |
0.11 |
0.07 |
Stock adjustment |
-0.01 |
- |
-0.11 |
0.10 |
0.08 |
Raw material |
0.63 |
0.62 |
0.79 |
0.49 |
0.48 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.25 |
0.26 |
0.18 |
0.25 |
0.26 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.39 |
0.40 |
0.36 |
0.38 |
0.25 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
Taxation |
- |
0.01 |
0.01 |
- |
0.01 |
Net profit / loss |
0.02 |
0.03 |
0.03 |
- |
0.02 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
4.06 |
4.06 |
4.06 |
4.06 |
4.06 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
3.97 |
5.49 |
1.04 |
2.35 |
6.64 |
GPM (%) |
3.36 |
4.80 |
5.18 |
2.49 |
4.01 |
NPM (%) |
1.15 |
2.15 |
2.37 |
0.36 |
1.36 |